In addition, mutations in, the gene encoding for DNaseI (DNASE1) could also cause a reduction in the levels of plasma DNaseI in a subset of BC patients, as occurs for some patients with systemic lupus erythematosus who develop lupus nephritis (39), a fact that should be addressed in future studies. This evidence concerns the gene DNASE1 and breast cancer.